ONKURE THERAPEUTICS, INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets
ONKURE THERAPEUTICS, INC. (OKUR) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $65.50 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2026-03-12
- 2025-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $65.50M.
- 2025-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $65.50M.
- 2025-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $65.50M.
- 2025-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $65.50M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets |
|---|---|
| 2025-12-31 | $65.50M 10-K · filed 2026-03-12 |
| 2025-09-30 | $65.50M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $65.50M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $65.50M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $65.50M 10-K · filed 2025-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |